ABOUT THIS PROSPECTUS
This document is called a prospectus and is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a shelf registration process. Under this process we may, from time to time, offer and sell our ordinary shares in one or more offerings, up to an aggregate dollar amount of $150 million. In addition, the Selling Shareholders named herein my offer, from time to time, up to 331,000 Ordinary Shares. The offer and sale of securities under this prospectus may be made from time to time, in one or more offerings, in any manner described under the section in this prospectus entitled Plan of Distribution.
This prospectus only provides you with a general description of our ordinary shares that we and the Selling Shareholders may offer. Each time we sell our ordinary shares, we will provide a prospectus supplement containing specific information about the offering, if required. Any such prospectus supplement may include a discussion of any risk factors or other special considerations that apply to that offering. The prospectus supplement may also add, update or change the information in this prospectus. If there is any inconsistency between the information in this prospectus and any prospectus supplement, you should rely on the information in that prospectus supplement. Before purchasing any of our ordinary shares, you should carefully read both this prospectus and any prospectus supplement together with additional information incorporated by reference herein and described under the headings Where You Can Find More Information and Incorporation By Reference.
The registration statement containing this prospectus, including exhibits to the registration statement, provides additional information about us and the securities offered under this prospectus. The registration statement can be read on the SEC website or at the SEC office mentioned under the heading Where You Can Find More Information.
When acquiring any ordinary shares described in this prospectus, you should rely only on the information provided in this prospectus and in any applicable prospectus supplement, including the information incorporated by reference. Neither we nor any underwriter, dealer or agent have authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not offering our ordinary shares in any jurisdiction where the offer or sale is prohibited. You should not assume that the information in this prospectus, any prospectus supplement or any document incorporated by reference is truthful or complete at any date other than the date mentioned on the cover page of any such document.
We and the Selling Shareholders may sell our ordinary shares to underwriters who will sell the securities to the public at a fixed offering price or at varying prices determined at the time of sale. The applicable prospectus supplement will contain the names of the underwriters, dealers or agents, if any, together with the terms of offering, the compensation of those underwriters, dealers or agents and the net proceeds to us. Any underwriters, dealers or agents participating in the offering may be deemed underwriters within the meaning of the Securities Act of 1933, as amended, or the Securities Act.
Unless otherwise mentioned or unless the context requires otherwise, all references in this prospectus to:
Foamix, the Company, our company, the Registrant, us, we and our refer to Foamix Pharmaceuticals Ltd., an Israeli company, and its consolidated subsidiaries.
Our shares, ordinary shares and similar expressions refer to the Registrants ordinary shares, par value New Israeli Shekels 0.16 per share.
Dollars, US dollars or $ refer to United States Dollars.
Shekels, and NIS refer to New Israeli Shekels.
Companies Law refers to the Israeli Companies Law, 5759-1999, as amended.
Exchange Act refers to the Securities Exchange Act of 1934, as amended.
Securities Act refers to the Securities Act of 1933, as amended.
FINRA refers to the Financial Industry Regulatory Authority.
NASDAQ refers to the NASDAQ Global Market.
SEC refers to the United States Securities and Exchange Commission.